Are two agencies better than one? When it comes to the Food & Drug Administration, some key members of Congress—including the chair of the House Appropriations Subcommittee that controls FDA’s budget—think the answer is yes.
For the biotech and pharmaceutical industries, the last thing anyone wants to talk about is another overhaul at FDA. The...




